Jacob Chacko insider trades: Oric Pharmaceuticals (ORIC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jacob reports to the SEC
Open-market buys and sales
28 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | ORIC | ↓ Sell | 33,374 | $9.06 | $302K | Direct | Dec 17, 2025 (1d) |
| Oct 6, 2025 | ORIC | ↓ Sell | 37,461 | $12.32 | $462K | Direct | Oct 8, 2025 (2d) |
| Oct 1, 2025 | ORIC | ↓ Sell | 87,539 | $12.04 | $1.1M | Direct | Oct 2, 2025 (1d) |
| Sep 22, 2025 | ORIC | ↓ Sell | 125,000 | $10.80 | $1.3M | Direct | Sep 24, 2025 (2d) |
| Dec 16, 2024 | ORIC | ↓ Sell | 24,660 | $8.28 | $204K | Direct | Dec 17, 2024 (1d) |
| Mar 6, 2024 | ORIC | ↓ Sell | 40,000 | $16.21 | $648K | Direct | Mar 8, 2024 (2d) |
| Feb 7, 2024 | ORIC | ↓ Sell | 40,000 | $12.23 | $489K | Direct | Feb 8, 2024 (1d) |
| Dec 15, 2023 | ORIC | ↓ Sell | 14,539 | $8.58 | $125K | Direct | Dec 19, 2023 (4d) |
| Jul 11, 2023 | ORIC | ↓ Sell | 15,664 | $8.01 | $125K | Direct | Jul 11, 2023 (0d) |
| Jul 5, 2023 | ORIC | ↓ Sell | 4,336 | $8.01 | $35K | Direct | Jul 7, 2023 (2d) |
| Jun 26, 2023 | ORIC | ↓ Sell | 20,000 | $8.03 | $161K | Direct | Jun 28, 2023 (2d) |
| Apr 21, 2023 | FDMT | ↓ Sell | 5,000 | $20.05 | $100K | Direct | Apr 25, 2023 (4d) |
| Dec 15, 2022 | ORIC | ↓ Sell | 5,764 | $3.25 | $19K | Direct | Dec 16, 2022 (1d) |
| May 13, 2022 | ORIC | ↑ Buy | 450,000 | $2.86 | $1.3M | Direct | May 13, 2022 (0d) |
| Mar 25, 2022 | ORIC | ↑ Buy | 350,000 | $4.92 | $1.7M | Direct | Mar 25, 2022 (0d) |
| Sep 15, 2021 | ORIC | ↓ Sell | 8,156 | $25.05 | $204K | Direct | Sep 16, 2021 (1d) |
| Sep 13, 2021 | ORIC | ↓ Sell | 5,743 | $25.05 | $144K | Direct | Sep 14, 2021 (1d) |
| Sep 8, 2021 | ORIC | ↓ Sell | 6,181 | $25.11 | $155K | Direct | Sep 9, 2021 (1d) |
| May 27, 2021 | ORIC | ↓ Sell | 400 | $25.07 | $10K | Direct | May 28, 2021 (1d) |
| May 24, 2021 | ORIC | ↓ Sell | 7,270 | $25.15 | $183K | Direct | May 24, 2021 (0d) |
| May 18, 2021 | ORIC | ↓ Sell | 27,778 | $25.34 | $704K | Direct | May 18, 2021 (0d) |
| May 13, 2021 | ORIC | ↓ Sell | 2,220 | $25.13 | $56K | Direct | May 13, 2021 (0d) |
| Apr 30, 2021 | ORIC | ↓ Sell | 1,300 | $25.14 | $33K | Direct | Apr 30, 2021 (0d) |
| Apr 1, 2021 | ORIC | ↓ Sell | 800 | $25.09 | $20K | Direct | Apr 5, 2021 (4d) |
| Mar 17, 2016 | RXDX | ↑ Buy | 10,000 | $5.63 | $56K | Direct | Mar 21, 2016 (4d) |
| Dec 16, 2015 | RXDX | ↑ Buy | 1,500 | $12.00 | $18K | Direct | Dec 17, 2015 (1d) |
| Nov 24, 2014 | RXDX | ↑ Buy | 1,598 | $6.46 | $10K | Direct | Nov 24, 2014 (0d) |
| Aug 19, 2014 | RXDX | ↑ Buy | 1,840 | $7.53 | $14K | Direct | Aug 19, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ORIC insiders
Open-market trades in the last 12 months
About Jacob Chacko's insider trades
Jacob Chacko is President and CEO at Oric Pharmaceuticals (ORIC). Since Aug 19, 2014, Jacob has reported 6 open-market purchases worth $3.1M and 22 sales worth $6.6M on SEC Form 4. In the last 12 months: 1 sale ($302K).
Their filings also include grants and awards (23 filings), option exercises (5 filings), shares returned to the company (2 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ORIC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.